Byhealth Co., Ltd

Equities

300146

CNE100000Y84

Food Processing

End-of-day quote Shenzhen S.E. 18:00:00 2024-06-27 EDT 5-day change 1st Jan Change
13.55 CNY -1.02% Intraday chart for Byhealth Co., Ltd -0.88% -20.43%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Byhealth Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Byhealth Co., Ltd Approves Cash Dividend for the Year 2023 CI
Tranche Update on Byhealth Co., Ltd's Equity Buyback Plan announced on November 1, 2023. CI
Byhealth Co., Ltd Announces Profit Distribution Proposal for 2023 CI
BY-Health's 2023 Profit Rises 26% as Revenue Jumps 20% MT
Byhealth Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Byhealth Co., Ltd's Equity Buyback Plan announced on November 1, 2023. CI
Byhealth Co., Ltd announces an Equity Buyback for CNY 300 million worth of its shares. CI
Byhealth Co., Ltd authorizes a Buyback Plan. CI
Byhealth Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Provexis notes regulatory filing for Fruitflow in China AN
Provexis' Local Partner Files for New Health Function Claim for Foods in China; Rises 12% MT
Provexis plc Announces Byhealth Co., Ltd Regulatory Filing with Chinese SAMR CI
Byhealth Co. Ltd. Approves Executive Appointments CI
Byhealth Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Byhealth Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Byhealth Co.,Ltd Announces Final Dividend Share A for 2022, Payable on April 21, 2023 CI
Byhealth Co.,Ltd Approves Dividend for the Year 2022 CI
Byhealth Co.,Ltd Proposes Final Cash Dividend for 2022 CI
BY-Health Sees Up to 30% Profit Slump in 2022 MT
By-health Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
By-health Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
By-health Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
By-Health Co., Ltd. Implements Cash Dividend for 2021, Payable on 13 April 2022 CI
By-Health Co., Ltd. Approves Cash Dividend for 2021 CI
Chart Byhealth Co., Ltd
More charts
Byhealth Co Ltd is a China-based company mainly engaged in the research, development, production and sales of dietary nutritional supplements. The Company's products principally include immunity-enhancing products such as protein powder, women's health products such as collagen, bone health products such as glucosamine chondroitin calcium tablets, as well as vitamin products such as multivitamins. The Company's products are mainly sold online and offline through brands such as By-Health, Jianliduo and Lifespace. The Company also provides health self-testing services such as bone health tests, cardiovascular disease and diabetes tests, bone and joint self-tests, basic health tests, and sleep quality tests. The Company mainly conducts its businesses in domestic and overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
13.55 CNY
Average target price
22.19 CNY
Spread / Average Target
+63.78%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300146 Stock
  4. News Byhealth Co., Ltd
  5. BY-Health Sees Up to 30% Profit Slump in 2022